Skye Bioscience (SKYE) Common Equity (2012 - 2026)
Skye Bioscience's Common Equity came in at -$497,307 for Q2 2026, compared with $43.68 million a year earlier.
Powered by 
Analysis
Skye Bioscience (SKYE) Common Equity (2012 - 2026) Analysis & Trends
At the end of FY2025, Skye Bioscience's Common Equity was $20.02 million, down 70.6% from FY2024.
- Common Equity carries a five-year compound annual growth rate of 113.6% (FY2020 to FY2025).
- Going back by year, Common Equity was $68.15 million in FY2024, -$2.13 million in FY2023, -$3.01 million in FY2022 and $5.86 million in FY2021.
- The Q2 2026 figure represents the lowest quarterly Common Equity since Q4 2023.
- Business Quant data shows SKYE's Common Equity at $9.01 million (Q1 2026), $20.02 million (Q4 2025) and $32.84 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Skye Bioscience | 7.07 Mn | 7.07 Mn | - | -497,307.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -497,307.00 |
| Mar 31, 2026 | 9.01 Mn |
| Dec 31, 2025 | 20.02 Mn |
| Sep 30, 2025 | 32.84 Mn |
| Jun 30, 2025 | 43.68 Mn |
| Mar 31, 2025 | 59.25 Mn |
| Dec 31, 2024 | 68.15 Mn |
| Sep 30, 2024 | 75.80 Mn |
| Jun 30, 2024 | 72.81 Mn |
| Mar 31, 2024 | 78.88 Mn |
| Dec 31, 2023 | -2.13 Mn |
| Sep 30, 2023 | 1.70 Mn |
| Jun 30, 2023 | -7.79 Mn |
| Mar 31, 2023 | -4.78 Mn |
| Dec 31, 2022 | -3.01 Mn |
| Sep 30, 2022 | -3.28 Mn |
| Jun 30, 2022 | -301,822.00 |
| Mar 31, 2022 | 2.97 Mn |
| Dec 31, 2021 | 5.86 Mn |
| Sep 30, 2021 | 8.26 Mn |
API Access
Skye Bioscience Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=SKYE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "SKYE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=SKYE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();